We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$73.6B
AUM Growth
+$1.15B
Cap. Flow
-$3.6B
Cap. Flow %
-4.89%
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$269M
2
MSFT icon
Microsoft
MSFT
+$172M
3
AMZN icon
Amazon
AMZN
+$114M
4
DIS icon
Walt Disney
DIS
+$62.4M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.8M

Sector Composition

Rank Sector Weight
1 Technology 22.61%
2 Financials 14.26%
3 Healthcare 12.86%
4 Consumer Discretionary 12.27%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
26
Cisco
CSCO
$457B
$396M 0.54%
7,656,462
-420,702
-5% -$19.7M
ABT icon
27
Abbott
ABT
$183B
$385M 0.52%
3,210,556
-195,774
-6% -$23.2M
KO icon
28
Coca-Cola
KO
$377B
$367M 0.5%
6,964,739
-465,115
-6% -$23.4M
PEP icon
29
PepsiCo
PEP
$190B
$352M 0.48%
2,489,004
-148,180
-6% -$20.3M
CVX icon
30
Chevron
CVX
$392B
$352M 0.48%
3,359,177
-177,244
-5% -$17.3M
NFLX icon
31
Netflix
NFLX
$299B
$350M 0.48%
6,712,520
-408,070
-6% -$21.6M
WMT icon
32
Walmart Inc
WMT
$885B
$330M 0.45%
7,278,441
-400,704
-5% -$18.6M
TXN icon
33
Texas Instruments
TXN
$252B
$326M 0.44%
1,726,547
-107,529
-6% -$18.7M
PFE icon
34
Pfizer
PFE
$143B
$326M 0.44%
8,991,891
-439,043
-5% -$15.6M
CRM icon
35
Salesforce
CRM
$151B
$325M 0.44%
1,532,278
-81,929
-5% -$18.2M
AVGO icon
36
Broadcom
AVGO
$1.85T
$318M 0.43%
6,853,490
-256,540
-4% -$11.9M
MRK icon
37
Merck
MRK
$322B
$314M 0.43%
4,268,029
-137,213
-3% -$10.1M
MCD icon
38
McDonald's
MCD
$192B
$310M 0.42%
1,382,314
-64,354
-4% -$13.8M
ACN icon
39
Accenture
ACN
$102B
$307M 0.42%
1,110,334
-65,504
-6% -$16.9M
ABBV icon
40
AbbVie
ABBV
$443B
$307M 0.42%
2,833,412
-160,379
-5% -$17.2M
NKE icon
41
Nike
NKE
$61.9B
$293M 0.4%
2,205,624
-187,879
-8% -$26.1M
COST icon
42
Costco
COST
$422B
$293M 0.4%
829,958
-43,173
-5% -$15M
TMO icon
43
Thermo Fisher Scientific
TMO
$213B
$292M 0.4%
640,612
-43,793
-6% -$20.9M
NEE icon
44
NextEra Energy
NEE
$181B
$270M 0.37%
3,577,391
-195,587
-5% -$15.3M
WFC icon
45
Wells Fargo
WFC
$261B
$269M 0.37%
6,897,816
-445,556
-6% -$15.8M
UNP icon
46
Union Pacific
UNP
$174B
$269M 0.37%
1,222,580
-74,591
-6% -$15.7M
MDT icon
47
Medtronic
MDT
$109B
$268M 0.36%
2,269,633
-139,885
-6% -$16.4M
LLY icon
48
Eli Lilly
LLY
$1.02T
$264M 0.36%
1,415,500
-95,984
-6% -$18.8M
QCOM icon
49
Qualcomm
QCOM
$155B
$263M 0.36%
1,983,260
-108,076
-5% -$15.6M
AMGN icon
50
Amgen
AMGN
$208B
$259M 0.35%
1,041,425
-98,088
-9% -$23.4M

Similar funds

RhumbLine Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.

  • RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
  • RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
  • RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
  • RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
  • RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
  • RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.

Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.